Last updated: 2 months ago
Neumora Therapeutics' Leadership Shake-Up: CEO Transition Report
Neumora Therapeutics (NASDAQ: NMRA) files Form 8-K/A on Feb 13, 2025, detailing CEO transition and strategic changes.
Posts With Tag executive employment agreement
Showing 1 - 1 of 1 Post